
    
      A phase 2, randomized, double masked clinical, parallel-group clinical trial to evaluate the
      efficacy and safety of PRO-148 ophthalmic solution compared with SYSTANE Â® ophthalmic
      solution for the treatment of signs and symptoms of mild-to-moderate dry eye syndrome.
    
  